Johnson & Johnson said Sandra Peterson, currently a Bayer executive, will take on the new role of group worldwide chairman, overseeing a consent decree at the company's troubled manufacturing plants that produce over-the-counter drugs.
Beginning December 1, Peterson will oversee information technology and the global supply chain, as well as J&J's vast consumer business, which makes products including Tylenol, baby shampoo and Band-Aids, the company said on September 13.
Peterson, 52, will also become a member of the J&J executive committee, the company said.
J&J's McNeil Consumer Healthcare has been operating under a consent decree after three of its manufacturing plants failed to curb quality lapses that had sparked a flood of recalls for its non-prescription medicines, such as Tylenol painkiller. Over the past couple of years, faulty manufacturing has prompted J&J's McNeil unit to recall millions of bottles and packages of Tylenol, Motrin, Rolaids, Benadryl and other products. Some of these recalls affected the company's distribution world-wide.